Fitch Ratings Fitch Rates Abbott Notes Offering at A(EXP) The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available. Fitch Assigns BBB Rating to Thermo Fisher Scientific €1.6B Senior Notes Offering The rating agency said it expects that the company will use the proceeds from the offering to finance its $4.2 billion acquisition of FEI. Thermo Fisher Scientific Plans Offering of €600M in Senior Notes Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook. PerkinElmer Prices €500M Senior Note Offering The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable. Thermo Fisher Prices $1B of Senior Notes The firm plans to use the proceeds, along with cash on hand, to redeem its outstanding $1 billion senior notes that mature August 15. Apr 4, 2016 Thermo Fisher Senior Notes Offering Rated BBB by Fitch Mar 2, 2016 Fitch Affirms Thermo Fisher Ratings, Stable Outlook Sep 17, 2015 Fitch Upgrades PerkinElmer Debt Rating Apr 22, 2015 Fitch Affirms BBB Rating for Quest Mar 5, 2015 Fitch Assigns BBB Rating to Quest's Senior Notes Offering Nov 10, 2014 Fitch Affirms Bio-Rad Ratings At BBB- Nov 6, 2014 Thermo Fisher Plans $800M Senior Notes Offering; Fitch Issues BBB Rating for Firm's Notes Nov 3, 2014 Fitch Affirms Agilent's Long-term Debt Ratings at BBB+; Company Completes Keysight Spin Off Dec 4, 2013 Fitch Downgrades Thermo Fisher's Issuer Default Rating Nov 22, 2013 In Brief This Week: Bio-Rad; Fitch, Abbott; Gentris; Indiana Biosciences Research Institute; Strand Life Sciences; Oncospire Genomics Sep 19, 2013 Fitch Affirms Agilent Debt Ratings; Revises Outlook to Stable Jun 18, 2013 UPDATE: Agilent to Offer Senior Notes; Fitch Rates Offering BBB+ Apr 16, 2013 Fitch Places Thermo Fisher, Life Tech Ratings on Negative Watch after Announcement of $13.6B Deal Apr 12, 2013 Fitch Affirms BBB+ Rating on Agilent's $2.8B of Debt Feb 25, 2013 Quest Selling HemoCue to Danaher's Radiometer; Fitch Affirms Quest's BBB+ Rating Jan 29, 2013 Fitch Places Life Tech's Ratings on Evolving Watch Following Acquisition Speculation Nov 14, 2012 Bio-Rad Ratings Affirmed by Fitch Sep 21, 2012 Fitch Affirms PerkinElmer Ratings, Saying Outlook is Stable Sep 10, 2012 Agilent Prices Public Offering of Senior Notes at $400M Jul 17, 2012 Fitch Downgrades Thermo Fisher IDR, Senior Secured Ratings to BBB+ Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.